Differences in thinning and thickening of the cartilage, subregions of the cartilage, and OVs did not reach statistical significance between the sprifermin‐ and placebo‐treated patients in these dose groups.
← all excerpts
Brief report: intraarticular sprifermin not only increases cartilage thickness, but also reduces cartilage loss: location-independent post hoc analysis using magnetic resonance imaging.
1
—
—